Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

932 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health Technology Intervention After Hospitalization for Schizophrenia: Service Utilization and User Satisfaction.
Baumel A, Correll CU, Hauser M, Brunette M, Rotondi A, Ben-Zeev D, Gottlieb JD, Mueser KT, Achtyes ED, Schooler NR, Robinson DG, Gingerich S, Marcy P, Meyer-Kalos P, Kane JM. Baumel A, et al. Among authors: kane jm. Psychiatr Serv. 2016 Sep 1;67(9):1035-8. doi: 10.1176/appi.ps.201500317. Epub 2016 Jun 1. Psychiatr Serv. 2016. PMID: 27247171
The prevalence of tardive dyskinesia.
Woerner MG, Kane JM, Lieberman JA, Alvir J, Bergmann KJ, Borenstein M, Schooler NR, Mukherjee S, Rotrosen J, Rubinstein M, et al. Woerner MG, et al. Among authors: kane jm. J Clin Psychopharmacol. 1991 Feb;11(1):34-42. J Clin Psychopharmacol. 1991. PMID: 1674949
Research diagnoses for tardive dyskinesia.
Schooler NR, Kane JM. Schooler NR, et al. Among authors: kane jm. Arch Gen Psychiatry. 1982 Apr;39(4):486-7. doi: 10.1001/archpsyc.1982.04290040080014. Arch Gen Psychiatry. 1982. PMID: 6121550 No abstract available.
Tardive dyskinesia workgroup report.
Kane JM, Schooler NR. Kane JM, et al. Psychopharmacol Bull. 1980 Jul;16(3):35-6. Psychopharmacol Bull. 1980. PMID: 7403396 No abstract available.
Dose response of prophylactic antipsychotics.
Davis JM, Kane JM, Marder SR, Brauzer B, Gierl B, Schooler N, Casey DE, Hassan M. Davis JM, et al. Among authors: kane jm. J Clin Psychiatry. 1993 Mar;54 Suppl:24-30. J Clin Psychiatry. 1993. PMID: 8097195 Review.
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.
Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID, Hargreaves WA, Kane JM, Ninan PT, Frances A, Jacobs M, Lieberman JA, Mance R, Simpson GM, Woerner MG. Schooler NR, et al. Among authors: kane jm. Arch Gen Psychiatry. 1997 May;54(5):453-63. doi: 10.1001/archpsyc.1997.01830170079011. Arch Gen Psychiatry. 1997. PMID: 9152099 Clinical Trial.
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy.
Kane JM, Aguglia E, Altamura AC, Ayuso Gutierrez JL, Brunello N, Fleischhacker WW, Gaebel W, Gerlach J, Guelfi JD, Kissling W, Lapierre YD, Lindström E, Mendlewicz J, Racagni G, Carulla LS, Schooler NR. Kane JM, et al. Eur Neuropsychopharmacol. 1998 Feb;8(1):55-66. doi: 10.1016/s0924-977x(97)00045-x. Eur Neuropsychopharmacol. 1998. PMID: 9452941
932 results